相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Adult patients with acute lymphoblastic leukemia and molecular failure display a poor prognosis and are candidates for stem cell transplantation and targeted therapies
Nicola Goekbuget et al.
BLOOD (2012)
Deep-sequencing approach for minimal residual disease detection in acute lymphoblastic leukemia
Malek Faham et al.
BLOOD (2012)
CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease
Francesco Mannelli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Time point-dependent concordance of flow cytometry and real-time quantitative polymerase chain reaction for minimal residual disease detection in childhood acute lymphoblastic leukemia
Giuseppe Gaipa et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2012)
Prevalence and dynamics of bcr-abl kinase domain mutations during imatinib treatment differ in patients with newly diagnosed and recurrent bcr-abl positive acute lymphoblastic leukemia
H. Pfeifer et al.
LEUKEMIA (2012)
Newly diagnosed acute lymphoblastic leukemia in China (II): prognosis related to genetic abnormalities in a series of 1091 cases
J-Q Mi et al.
LEUKEMIA (2012)
EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
J. J. M. van Dongen et al.
LEUKEMIA (2012)
Pediatric-inspired intensified therapy of adult T-ALL reveals the favorable outcome of NOTCH1/FBXW7 mutations, but not of low ERG/BAALC expression: a GRAALL study
Raouf Ben Abdelali et al.
BLOOD (2011)
New Strategies in Acute Lymphoblastic Leukemia: Translating Advances in Genomics into Clinical Practice
Charles G. Mullighan
CLINICAL CANCER RESEARCH (2011)
Philadelphia-positive acute lymphoblastic leukemia patients already harbor BCR-ABL kinase domain mutations at low levels at the time of diagnosis
Simona Soverini et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Current Therapeutic Strategies in Adult Acute Lymphoblastic Leukemia
Adele K. Fielding
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2011)
Targeted Therapy With the T-Cell-Engaging Antibody Blinatumomab of Chemotherapy-Refractory Minimal Residual Disease in B-Lineage Acute Lymphoblastic Leukemia Patients Results in High Response Rate and Prolonged Leukemia-Free Survival
Max S. Topp et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Current Treatment of Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Adele K. Fielding
HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM (2011)
Immunologic minimal residual disease detection in acute lymphoblastic leukemia: A comparative approach to molecular testing
Elaine Coustan-Smith et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study
Valentino Conter et al.
BLOOD (2010)
Minimal residual disease is a significant predictor of treatment failure in non T-lineage adult acute lymphoblastic leukaemia: final results of the international trial UKALL XII/ECOG2993
Bella Patel et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia
Thomas Burmeister et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Chemoimmunotherapy With a Modified Hyper-CVAD and Rituximab Regimen Improves Outcome in De Novo Philadelphia Chromosome-Negative Precursor B-Lineage Acute Lymphoblastic Leukemia
Deborah A. Thomas et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Standardized MRD quantification in European ALL trials: Proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M. Brueggemann et al.
LEUKEMIA (2010)
Detection of Residual B Precursor Lymphoblastic Leukemia by Uniform Gating Flow Cytometry
Ester Mejstrikova et al.
PEDIATRIC BLOOD & CANCER (2010)
NOTCH1/FBXW7 mutation identifies a large subgroup with favorable outcome in adult T-cell acute lymphoblastic leukemia (T-ALL): a Group for Research on Adult Acute Lymphoblastic Leukemia (GRAALL) study
Vahid Asnafi et al.
BLOOD (2009)
Prognostic significance of CD20 expression in adults with de novo precursor B-lineage acute lymphoblastic leukemia
Deborah A. Thomas et al.
BLOOD (2009)
Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)
Renato Bassan et al.
BLOOD (2009)
The Extent of Minimal Residual Disease Reduction After the First 4-Week Imatinib Therapy Determines Outcome of Allogeneic Stem Cell Transplantation in Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Seok Lee et al.
CANCER (2009)
Prognostic Implications of NOTCH1 and FBXW7 Mutations in Adults With T-Cell Acute Lymphoblastic Leukemia Treated on the MRC UKALLXII/ECOG E2993 Protocol
Marc R. Mansour et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
IKZF1 (Ikaros) Deletions in BCR-ABL1-Positive Acute Lymphoblastic Leukemia Are Associated With Short Disease-Free Survival and High Rate of Cumulative Incidence of Relapse: A GIMEMA AL WP Report
Giovanni Martinelli et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Pediatric-Inspired Therapy in Adults With Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia: The GRAALL-2003 Study
Francoise Huguet et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
V. H. J. Van der Velden et al.
LEUKEMIA (2009)
CD20 up-regulation in pediatric B-cell precursor acute lymphoblastic leukemia during induction treatment: setting the stage for anti-CD20 directed immunotherapy
Michael N. Dworzak et al.
BLOOD (2008)
What determines the outcomes for adolescents and young adults with acute lymphoblastic leukemia treated on cooperative group protocols? A comparison of Children's Cancer Group and Cancer and Leukemia Group B studies
Wendy Stock et al.
BLOOD (2008)
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study
Michael J. Borowitz et al.
BLOOD (2008)
B-cell reconstitution after allogeneic SCT impairs minimal residual disease monitoring in children with ALL
E. Fronkova et al.
BONE MARROW TRANSPLANTATION (2008)
Status of minimal residual disease after induction predicts outcome in both standard and high-risk Ph-negative adult acute lymphoblastic leukaemia.: The Polish Adult Leukemia Group ALL 4-2002 MRD Study
Jerzy Holowiecki et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Generation of flow cytometry data files with a potentially infinite number of dimensions
Carlos E. Pedreira et al.
CYTOMETRY PART A (2008)
Somatically acquired JAK1 mutations in adult acute lymphoblastic leukemia
Elisabetta Flex et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Minimal residual disease-directed risk stratification using real-time quantitative PCR analysis of immunoglobulin and T-cell receptor gene rearrangements in the international multicenter trial AIEOP-BFM ALL 2000 for childhood acute lymphoblastic leukemia
T. Flohr et al.
LEUKEMIA (2008)
Impact of cytogenetics on the outcome of adult acute lymphoblastic leukemia: results of Southwest Oncology Group 9400 study
Vinod Pullarkat et al.
BLOOD (2008)
In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolidation/maintenance chemotherapy in all patients: final results of the International ALL Trial (MRC UKALL XII/ECOG E2993)
Anthony H. Goldstone et al.
BLOOD (2008)
Non-specific amplification of patient-specific Ig/TCR gene rearrangements depends on the time point during therapy: implications for minimal residual disease monitoring
V. H. J. van der Velden et al.
LEUKEMIA (2008)
Low ERG and BAALC expression identifies a new subgroup of adult acute T-Lymphoblastic leukemia with a highly favorable outcome
Claudia D. Baldus et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Kinase domain mutations of BCR-ABL frequently precede imatinib-based therapy and give rise to relapse in patients with de novo Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
Heike Pfeifer et al.
BLOOD (2007)
Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph plus ALL)
Oliver G. Ottmann et al.
CANCER (2007)
Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia
Orietta Spinelli et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2007)
Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial
Anthony V. Moorman et al.
BLOOD (2007)
Molecular relapse in adult standard-risk ALL patients detected by prospective MRD monitoring during and after maintenance treatment:: data from the GMALL 06/99 and 07/03 trials
Thorsten Raff et al.
BLOOD (2007)
Treatment outcome in young adults and children >10 years of age with acute lymphoblastic leukemia in Sweden -: A comparison between a pediatric protocol and an adult protocol
Helene Hallbook et al.
CANCER (2006)
Poor outcome of adult acute lymphoblastic leukemia patients carrying the (1;19)(q23;p13) translocation
PP Piccaluga et al.
LEUKEMIA & LYMPHOMA (2006)
Monitoring minimal residual disease by quantification of genomic chromosomal breakpoint sequences in acute leukemias with MLL aberrations
T Burmeister et al.
LEUKEMIA (2006)
Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia
M Brüggemann et al.
BLOOD (2006)
Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993
JM Rowe et al.
BLOOD (2005)
Immunophenotypic modulation in childhood precursor-B-ALL can be mimicked in vitro and is related to the induction of cell death
A van der Sluijs-Gelling et al.
LEUKEMIA (2005)
Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
B Wassmann et al.
BLOOD (2005)
Concurrent detection of minimal residual disease (MRD) in childhood acute lymphoblastic leukaemia by flow cytometry and real-time PCR
G Kerst et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia
M Bruggemann et al.
LEUKEMIA (2004)
Analysis of minimal residual disease in childhood acute lymphoblastic leukemia:: comparison between RQ-PCR analysis of Ig/TcR gene rearrangements and multicolor flow cytometric immunophenotyping
M Malec et al.
LEUKEMIA (2004)
Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia
GAM Neale et al.
LEUKEMIA (2004)
Minimal residual disease-based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome-positive acute lymphoblastic leukemia
S Lee et al.
BLOOD (2003)
Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias:: early immunophenotypic evaluation has high clinical value
MB Vidriales et al.
BLOOD (2003)
Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults?: Comparison of the French FRALLE-93 and LALA-94 trials
N Boissel et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Risk factors for adults with Philadelphia-chromosome-positive acute lymphoblastic leukaemia in remission treated with allogeneic bone marrow transplantation: the potential of real-time quantitative reverse-transcription polymerase chain reaction
S Lee et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Risk-adapted treatment according to minimal residual disease in adult ALL
N Gökbuget et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2002)
Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia -: results of the prospective multicenter LALA-94 trial
H Dombret et al.
BLOOD (2002)
Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia
MN Dworzak et al.
BLOOD (2002)
Minimal residual disease tests provide an independent predictor of clinical outcome in adult acute lymphoblastic leukemia
FY Mortuza et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
C Eckert et al.
LANCET (2001)
Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR
M Brüggemann et al.
LEUKEMIA (2000)
分享论文
